New Freespira® Study Shows Nearly 80% of Patients are Panic Attack Free at One Year Post-Treatment

The drug-free, four-week at-home treatment produces lasting results

Danville, CA – (February 22, 2017) – Palo Alto Health Sciences, Inc. (PAHS), developer of the Freespira® at-home treatment for panic attacks and other symptoms of panic disorder, today announced the results of a new multi-center clinical trial which demonstrated compelling effectiveness across a broad spectrum of patient demographics and symptom severity. Continue reading “New Freespira® Study Shows Nearly 80% of Patients are Panic Attack Free at One Year Post-Treatment”

Clinical Results of Drug-Free Freespira® Treatment for Panic to be Presented at Clinical TMS Society Annual Meeting

Danville, CA – (May 15, 2017) – Palo Alto Health Sciences, Inc. (PAHS), developer of Freespira®, the only FDA-cleared digital therapeutic for panic attacks and symptoms of panic disorder, today announced that clinical results from the most recent trial will be presented at the Continue reading “Clinical Results of Drug-Free Freespira® Treatment for Panic to be Presented at Clinical TMS Society Annual Meeting”